Literature DB >> 24298912

Transabdominal coelocentesis as early source of fetal DNA for chromosomal and molecular diagnosis.

Adalgisa Pietropolli1, Roberta Vicario, Cristina Peconi, Stefania Zampatti, Maria Chiara Quitadamo, Maria Vittoria Capogna, Michele Ragazzo, Anna Maria Nardone, Diana Postorivo, Paola Spitalieri, Simona Sarta, Fabrizio Ratto, Giuseppe Novelli, Federica Sangiuolo, Emilio Piccione, Emiliano Giardina.   

Abstract

This study reports a comparative analysis between results of transabdominal coelocentesis and traditional invasive procedure in order to assess the usefulness of coelocentesis as a source of fetal DNA for molecular and chromosomal analysis. A number of 28 women were included in the study. A successful sampling of coelomic fluid was obtained in 25 women by transabdominal procedure. A positive amplification of DNA with QF-PCR techniques was obtained in 90% of cases, while 10% of cases failed to reveal interpretable results. Although all samples were cultured, the growth rate was not sufficient to determine karyotypes within 2 weeks. Five samples were selected to be analyzed by array-based comparative genomic hybridization (a-CGH) but the interpretation of these results was difficult and ambiguous. Our results suggest that transabdominal coelocentesis is suitable for the detection of single DNA variation and for QF-PCR analysis, while further experiments are needed to develop optimized protocols for traditional karyotyping and array-analysis.

Entities:  

Keywords:  Array-based comparative genomic hybridization; QF-PCR; coelomic fluid; fetal DNA; transabdominal coelocentesis

Mesh:

Year:  2014        PMID: 24298912     DOI: 10.3109/14767058.2013.871697

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  1 in total

1.  Celomic Fluid: Laboratory Workflow for Prenatal Diagnosis of Monogenic Diseases.

Authors:  Antonino Giambona; Margherita Vinciguerra; Filippo Leto; Filippo Cassarà; Viviana Tartaglia; Valentina Cigna; Emanuela Orlandi; Francesco Picciotto; Nourah H Al Qahtani; Eman S Alsulmi; Noor B Almandil; Sayed AbdulAzeez; J Francis Borgio; Aurelio Maggio
Journal:  Mol Diagn Ther       Date:  2022-02-17       Impact factor: 4.074

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.